UCLA researchers have developed a new combination immunotherapy to treat advanced brain cancer. The combination treatment works by preventing brain cancer cells from shielding themselves from a patient’s own immune responses. Read more...
Photo: Robert M. Prins, leader of the cancer research team that discovered effective immunity to glioblastoma requires a robust killer T cell response in order to attenuate immune cells within the tumor.(Courtesy of Robert Prins)





